| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sight Sciences, Inc. (SGHT) has 9 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. SGHT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.03M | $31.58M | - | |
| Other | 1.91M | $10.02M | - | |
| 10% | 1.39M | $7.29M | - | |
| Other | 832.3K | $4.36M | - | |
| COO | 600.0K | $3.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | Encrantz Staffan74 | Director, 10% Owner | Buy | 551,802 | $8.33 | $4,598,106.94 | +181.8% | +0.8% | +11.2% | |
| May 13, 2022 | Selnick Jesse | Chief Financial Officer | Buy | 5,000 | $8.28 | $41,400.00 | +2.0% | +19.8% | +21.1% | |
| Dec 1, 2021 | Encrantz Staffan74 | Director | Buy | 525,000 | $20.89 | $10,968,303.24 | +1.8% | -13.5% | -41.2% | |
| Nov 23, 2021 | Selnick Jesse | Chief Financial Officer | Buy | 10,000 | $18.44 | $184,393.00 | +0.5% | -15.8% | -44.6% | |
| Oct 18, 2021 | Encrantz Staffan74 | Director | Buy | 527,048 | $24.00 | $12,649,152.00 | +17.7% | -35.1% | -68.7% | |
| Jul 19, 2021 | D1 Capital Partners L.P.53 | 10% Owner | Buy | 700,000 | $24.00 | $16,800,000.00 | +13.6% | -29.4% | -70.2% |